Literature DB >> 19808498

Biophysical properties of 9 KCNQ1 mutations associated with long-QT syndrome.

Tao Yang1, Seo-Kyung Chung, Wei Zhang, Jonathan G L Mullins, Caroline H McCulley, Jackie Crawford, Judith MacCormick, Carey-Anne Eddy, Andrew N Shelling, John K French, Ping Yang, Jonathan R Skinner, Dan M Roden, Mark I Rees.   

Abstract

BACKGROUND: Inherited long-QT syndrome is characterized by prolonged QT interval on the ECG, syncope, and sudden death caused by ventricular arrhythmia. Causative mutations occur mostly in cardiac potassium and sodium channel subunit genes. Confidence in mutation pathogenicity is usually reached through family genotype-phenotype tracking, control population studies, molecular modeling, and phylogenetic alignments; however, biophysical testing offers a higher degree of validating evidence. METHODS AND
RESULTS: By using in vitro electrophysiological testing of transfected mutant and wild-type long-QT syndrome constructs into Chinese hamster ovary cells, we investigated the biophysical properties of 9 KCNQ1 missense mutations (A46T, T265I, F269S, A302V, G316E, F339S, R360G, H455Y, and S546L) identified in a New Zealand-based long-QT syndrome screening program. We demonstrate through electrophysiology and molecular modeling that 7 of the missense mutations have profound pathological dominant-negative loss-of-function properties, confirming their likely disease-causing nature. This supports the use of these mutations in diagnostic family screening. Two mutations (A46T, T265I) show suggestive evidence of pathogenicity within the experimental limits of biophysical testing, indicating that these variants are disease-causing via delayed- or fast-activation kinetics. Further investigation of the A46T family has revealed an inconsistent cosegregation of the variant with the clinical phenotype.
CONCLUSIONS: Electrophysiological characterization should be used to validate long-QT syndrome pathogenicity of novel missense channelopathies. When such results are inconclusive, great care should be taken with genetic counseling and screening of such families, and alternative disease-causing mechanisms should be considered.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19808498      PMCID: PMC2748886          DOI: 10.1161/CIRCEP.109.850149

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  25 in total

Review 1.  Novel insights in the congenital long QT syndrome.

Authors:  Xander H T Wehrens; Marc A Vos; Pieter A Doevendans; Hein J J Wellens
Journal:  Ann Intern Med       Date:  2002-12-17       Impact factor: 25.391

2.  Phosphorylation of the IKs channel complex inhibits drug block: novel mechanism underlying variable antiarrhythmic drug actions.

Authors:  Tao Yang; Hideaki Kanki; Dan M Roden
Journal:  Circulation       Date:  2003-06-30       Impact factor: 29.690

3.  Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel.

Authors:  Steven O Marx; Junko Kurokawa; Steven Reiken; Howard Motoike; Jeanine D'Armiento; Andrew R Marks; Robert S Kass
Journal:  Science       Date:  2002-01-18       Impact factor: 47.728

4.  Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2.

Authors:  I Splawski; J Shen; K W Timothy; M H Lehmann; S Priori; J L Robinson; A J Moss; P J Schwartz; J A Towbin; G M Vincent; M T Keating
Journal:  Circulation       Date:  2000-09-05       Impact factor: 29.690

5.  Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes.

Authors:  Ping Yang; Hideaki Kanki; Benoit Drolet; Tao Yang; Jian Wei; Prakash C Viswanathan; Stefan H Hohnloser; Wataru Shimizu; Peter J Schwartz; Marshall Stanton; Katherine T Murray; Kris Norris; Alfred L George; Dan M Roden
Journal:  Circulation       Date:  2002-04-23       Impact factor: 29.690

6.  Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome).

Authors:  Martin Tristani-Firouzi; Judy L Jensen; Matthew R Donaldson; Valeria Sansone; Giovanni Meola; Angelika Hahn; Said Bendahhou; Hubert Kwiecinski; Anna Fidzianska; Nikki Plaster; Ying-Hui Fu; Louis J Ptacek; Rabi Tawil
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

7.  Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death.

Authors:  Peter J Mohler; Jean-Jacques Schott; Anthony O Gramolini; Keith W Dilly; Silvia Guatimosim; William H duBell; Long-Sheng Song; Karine Haurogné; Florence Kyndt; Mervat E Ali; Terry B Rogers; W J Lederer; Denis Escande; Herve Le Marec; Vann Bennett
Journal:  Nature       Date:  2003-02-06       Impact factor: 49.962

8.  New KCNQ1 mutations leading to haploinsufficiency in a general population; Defective trafficking of a KvLQT1 mutant.

Authors:  Laetitia Gouas; Chloe Bellocq; Myriam Berthet; Franck Potet; Sophie Demolombe; Anne Forhan; Rachel Lescasse; Françoise Simon; Beverley Balkau; Isabelle Denjoy; Bernard Hainque; Isabelle Baró; Pascale Guicheney
Journal:  Cardiovasc Res       Date:  2004-07-01       Impact factor: 10.787

9.  The KCNQ1 (Kv7.1) COOH terminus, a multitiered scaffold for subunit assembly and protein interaction.

Authors:  Reuven Wiener; Yoni Haitin; Liora Shamgar; M Carmen Fernández-Alonso; Ariadna Martos; Orna Chomsky-Hecht; Germán Rivas; Bernard Attali; Joel A Hirsch
Journal:  J Biol Chem       Date:  2007-12-29       Impact factor: 5.157

10.  Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism.

Authors:  Igor Splawski; Katherine W Timothy; Leah M Sharpe; Niels Decher; Pradeep Kumar; Raffaella Bloise; Carlo Napolitano; Peter J Schwartz; Robert M Joseph; Karen Condouris; Helen Tager-Flusberg; Silvia G Priori; Michael C Sanguinetti; Mark T Keating
Journal:  Cell       Date:  2004-10-01       Impact factor: 41.582

View more
  16 in total

1.  Stop-codon and C-terminal nonsense mutations are associated with a lower risk of cardiac events in patients with long QT syndrome type 1.

Authors:  Martin H Ruwald; Xiaorong Xu Parks; Arthur J Moss; Wojciech Zareba; Jayson Baman; Scott McNitt; Jorgen K Kanters; Wataru Shimizu; Arthur A Wilde; Christian Jons; Coeli M Lopes
Journal:  Heart Rhythm       Date:  2015-08-28       Impact factor: 6.343

2.  Congenital long-QT syndrome in Addison's disease: a novel association.

Authors:  Sean M Lang; Nancy L Rollinson; Steven B Fishberger
Journal:  Pediatr Cardiol       Date:  2012-02-07       Impact factor: 1.655

Review 3.  Cardiac Delayed Rectifier Potassium Channels in Health and Disease.

Authors:  Lei Chen; Kevin J Sampson; Robert S Kass
Journal:  Card Electrophysiol Clin       Date:  2016-04-01

4.  Physical and functional interaction sites in cytoplasmic domains of KCNQ1 and KCNE1 channel subunits.

Authors:  Jerri Chen; Zhenning Liu; John Creagh; Renjian Zheng; Thomas V McDonald
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-12-13       Impact factor: 4.733

5.  Dysfunctional potassium channel subunit interaction as a novel mechanism of long QT syndrome.

Authors:  Michael Hoosien; Mary Ellen Ahearn; Robert J Myerburg; Thai V Pham; Todd E Miller; Marcel J Smets; Lisa Baumbach-Reardon; Ming-Lon Young; Amjad Farooq; Nanette H Bishopric
Journal:  Heart Rhythm       Date:  2013-01-02       Impact factor: 6.343

6.  Novel Kv7.1-phosphatidylinositol 4,5-bisphosphate interaction sites uncovered by charge neutralization scanning.

Authors:  Karina Eckey; Eva Wrobel; Nathalie Strutz-Seebohm; Lutz Pott; Nicole Schmitt; Guiscard Seebohm
Journal:  J Biol Chem       Date:  2014-06-19       Impact factor: 5.157

7.  An allosteric mechanism for drug block of the human cardiac potassium channel KCNQ1.

Authors:  Tao Yang; Jarrod A Smith; Brenda F Leake; Charles R Sanders; Jens Meiler; Dan M Roden
Journal:  Mol Pharmacol       Date:  2012-11-28       Impact factor: 4.436

8.  Characterization of a binding site for anionic phospholipids on KCNQ1.

Authors:  Alison M Thomas; Stephen C Harmer; Tapsi Khambra; Andrew Tinker
Journal:  J Biol Chem       Date:  2010-11-17       Impact factor: 5.157

9.  Genetic and forensic implications in epilepsy and cardiac arrhythmias: a case series.

Authors:  Sara Partemi; Monica Coll Vidal; Pasquale Striano; Oscar Campuzano; Catarina Allegue; Marianna Pezzella; Maurizio Elia; Pasquale Parisi; Vincenzo Belcastro; Susanna Casellato; Lucio Giordano; Massimo Mastrangelo; Nicola Pietrafusa; Salvatore Striano; Federico Zara; Amedeo Bianchi; Daniela Buti; Angela La Neve; Carlo Alberto Tassinari; Antonio Oliva; Ramon Brugada
Journal:  Int J Legal Med       Date:  2014-08-15       Impact factor: 2.686

10.  In silico directed mutagenesis identifies the CD81/claudin-1 hepatitis C virus receptor interface.

Authors:  Christopher Davis; Helen J Harris; Ke Hu; Heidi E Drummer; Jane A McKeating; Jonathan G L Mullins; Peter Balfe
Journal:  Cell Microbiol       Date:  2012-09-25       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.